Suppliers / Sichuan Huiyu Pharmaceutical

Sichuan Huiyu Pharmaceutical

China 53 employees Updated 9 July 2026

Sichuan Huiyu Pharmaceutical is an API and finished-dose manufacturer based in China. It holds 5 active US drug master files across a filed portfolio of 5 molecules. Its filings concentrate with NPRA (MY), UZPHARM (UZ) and MINSA (CR). Its GMP standing is certified by EMA and MHRA (UK).

5
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
20
filings across 5 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Neijiang, United Arab Emirates Not on file
NEIJIANG, China Not on file
Neijiang, China Not on file
China, China 3014500199

What they file, and where

Molecule Regulators Docs
Carfilzomib US FDA 1
Etoposide US FDA 1
Iron Sucrose US FDA 1
Lanreotide US FDA 1
Leucovorin Calcium US FDA 1

Also appears on these molecule pages

Carfilzomib API Etoposide API Lanreotide API Leucovorin API Oxaliplatin finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 7 None
UZPHARM (UZ) 6 None
MINSA (CR) 3 None
EDE (AE) 3 None
INVIMA (CO) 1 None
EMA None 3
MHRA (UK) None 1

Questions about Sichuan Huiyu Pharmaceutical

Does Sichuan Huiyu Pharmaceutical hold a US DMF or a CEP?
Sichuan Huiyu Pharmaceutical holds 5 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Sichuan Huiyu Pharmaceutical FDA-registered?
One site operated by Sichuan Huiyu Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Sichuan Huiyu Pharmaceutical manufacture?
4 registered sites are on record, in United Arab Emirates and China (Neijiang, Neijiang and China among others). Every site is listed on this page with the register it came from.
What does Sichuan Huiyu Pharmaceutical make?
5 molecules are on record against Sichuan Huiyu Pharmaceutical, including Carfilzomib, Etoposide, Iron Sucrose and Lanreotide. Each links through to that molecule's full manufacturer list.
Which regulators recognise Sichuan Huiyu Pharmaceutical's GMP?
Current GMP certificates are on record from EMA and MHRA (UK). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Sichuan Huiyu Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Dr Reddy's Laboratories shares 2 molecules MSN Laboratories shares 1 molecule Hetero shares 1 molecule Cipla shares 1 molecule Biophore India Pharmaceuticals shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates